Tumor Treating Fields therapy demonstrates increased overall survival in patients with unresectable pancreatic cancer. The novel therapy was safe and...
CRISPR gene editing based treatment reduced HAE attacks rates by up to 80%. NTLA-2002 was well tolerated by patients. The...
ALG-055009, a thyroid hormone receptor agonist, significantly reduced liver fat in patients with MASH after 12 weeks of treatment. ALG-055009...
Depemokimab was shown to reduce exacerbations in patients with severe asthma. The proportions of adverse events of Depemokimab and the...
Patients with chronic pain from osteoarthritis who received LEVI-04 had a 50% reduction in pain from baseline. LEVI-04 was well...
A dose-dependent slowing in Huntington's disease progression was observed after 24 months in patients receiving high-dose AMT-130. The gene therapy...
Patients on pemvidutide experienced only 21.9% of weight loss attributable to lean mass. Pemvidutide preserves muscle tissue and prioritizes fat...
Patients with familial chylomicronemia syndrome (FCS) treated with plozasiran demonstrated a maximum reduction of 98% in triglyceride levels at month...
Patients with pancreatitis on high-dose Auxora showed a 2.1-day improvement in time to solid food tolerance compared to the placebo...
DB-OTO gene therapy has been shown to improve auditory response in children with congenital hearing loss DB-OTO is a promising...
